LON:C4XD C4X Discovery (C4XD) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About C4X Discovery Stock (LON:C4XD) Get C4X Discovery alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.77 million shsAverage Volume1.18 million shsMarket Capitalization£30.27 millionP/E Ratio300.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom. Read More Receive C4XD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. C4XD Stock News HeadlinesC4X Discovery establishes in vivo proof of concept for its PAD4 inhibitor programmeSeptember 15, 2026 | finance.yahoo.comC4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreementSeptember 4, 2026 | finance.yahoo.comElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he says is the same size Nvidia was a decade ago. The company holds 150 patents protecting its core technology, and Brown believes Elon Musk could soon drive major demand for it. A key catalyst is set for November 11.October 14 at 1:00 AM | Brownstone Research (Ad)C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programmeSeptember 22, 2025 | uk.finance.yahoo.comPatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel diseaseSeptember 17, 2024 | markets.businessinsider.comC4X Discovery Holdings PLC: C4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finanznachrichten.deC4X Discovery Holdings PLC: C4X Discovery announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finanznachrichten.deC4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finance.yahoo.comSee More Headlines C4XD Stock Analysis - Frequently Asked Questions How were C4X Discovery's earnings last quarter? C4X Discovery Holdings plc (LON:C4XD) posted its quarterly earnings results on Wednesday, April, 29th. The company reported ($5.02) earnings per share for the quarter, topping analysts' consensus estimates of ($5.50) by $0.48. C4X Discovery had a net margin of 42.81% and a trailing twelve-month return on equity of 55.38%. Company Calendar Last Earnings4/29/2020Today10/14/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:C4XD CIKN/A Webwww.c4xdiscovery.com Phone+44-161-2355085FaxN/AEmployees49Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.04 Trailing P/E Ratio300.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£10.57 million Net Margins42.81% Pretax MarginN/A Return on Equity55.38% Return on Assets28.04% Debt Debt-to-Equity Ratio1.05 Current Ratio15.31 Quick Ratio9.82 Sales & Book Value Annual Sales£24.68 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.00 Book ValueGBX 10 per share Price / BookN/AMiscellaneous Outstanding Shares252,230,000Free FloatN/AMarket Cap£30.27 million OptionableNot Optionable Beta0.23 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:C4XD) was last updated on 4/25/2024 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4X Discovery Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share C4X Discovery With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
